Literature DB >> 26474871

Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma.

A M Mongan1, N Lynam-Lennon1, R Casey1, S Maher2, G Pidgeon1, J V Reynolds1, J O'Sullivan3.   

Abstract

PURPOSE: Oesophageal adenocarcinoma is an exemplar model of obesity-associated cancer. Locally advanced disease is treated with neoadjuvant chemoradiotherapy, and survival rates are highest in patients demonstrating a pathological response following neoadjuvant therapy. Given that 55 % of oesophageal adenocarcinoma patients are obese, uncovering the effect of adipose tissue on radioresponse is clinically relevant. This study investigates if adipose tissue activates genomic instability events in radioresponsive (OE33P) and radioresistant (OE33R) oesophageal cancer cell lines and tumour samples.
METHODS: OE33R and OE33P were cultured with adipose-conditioned media derived from oesophageal adenocarcinoma patients (n = 10). Anaphase bridges, a marker of genomic instability, were enumerated in both cell lines following treatment with adipose media, and normalised to cell number. Genomic instability is regulated by the spindle assembly complex. Expression of two spindle assembly complex genes (MAD2L2, BUB1B) was assessed using qPCR, and validated in patient tumour specimens from viscerally obese (n = 46) and nonobese patients (n = 41).
RESULTS: Adipose-conditioned media increased anaphase bridging in OE33R (p < 0.0001), with a threefold increase in OE33R compared to OE33P (p < 0.01). Levels of anaphase bridges in OE33R cells correlated with visceral obesity status as measured by waist circumference (R = 0.709, p = 0.03) and visceral fat area (R = 0.794, p = 0.006). Adipose tissue altered expression of MAD2L2 in vitro. In vivo, MAD2L2 expression was higher in viscerally obese oesophageal adenocarcinoma patients compared with nonobese patients (p < 0.05).
CONCLUSIONS: Anaphase bridge levels are influenced by obesity and radiosensitivity status in oesophageal adenocarcinoma. Furthermore, visceral adipose-conditioned media stimulates dysregulation of the spindle assembly complex in oesophageal adenocarcinoma patients.

Entities:  

Keywords:  Genomic instability; Obesity; Oesophageal cancer; Radiotherapy

Mesh:

Substances:

Year:  2015        PMID: 26474871     DOI: 10.1007/s12094-015-1411-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  33 in total

Review 1.  Culture of adipose tissue and isolated adipocytes.

Authors:  S K Fried; N Moustaid-Moussa
Journal:  Methods Mol Biol       Date:  2001

2.  ACP. Best Practice No 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting.

Authors:  N B Ibrahim
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

3.  Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma.

Authors:  Niamh Lynam-Lennon; John V Reynolds; Graham P Pidgeon; Joanne Lysaght; Laure Marignol; Stephen G Maher
Journal:  Radiat Res       Date:  2010-10-04       Impact factor: 2.841

4.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

5.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

6.  Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation.

Authors:  K K Wong; S Chang; S R Weiler; S Ganesan; J Chaudhuri; C Zhu; S E Artandi; K L Rudolph; G J Gottlieb; L Chin; F W Alt; R A DePinho
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents.

Authors:  Sylvain Ladoire; Franck Bonnetain; Mélanie Gauthier; Sylvie Zanetta; Jean Michel Petit; Séverine Guiu; Isabelle Kermarrec; Eric Mourey; Frederic Michel; Denis Krause; Patrick Hillon; Luc Cormier; François Ghiringhelli; Boris Guiu
Journal:  Oncologist       Date:  2011-01-06

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

10.  Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.

Authors:  Jason A Efstathiou; Ming-Hui Chen; Andrew A Renshaw; Marian J Loffredo; Anthony V D'Amico
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

View more
  2 in total

Review 1.  Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma.

Authors:  William Jiang; Jelske M de Jong; Richard van Hillegersberg; Matthew Read
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

Review 2.  Obesity, inflammation, and cancer in dogs: Review and perspectives.

Authors:  Pedro H Marchi; Thiago H A Vendramini; Mariana P Perini; Rafael V A Zafalon; Andressa R Amaral; Vanessa A Ochamotto; Juliano C Da Silveira; Maria L Z Dagli; Marcio A Brunetto
Journal:  Front Vet Sci       Date:  2022-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.